Search Tag: cirrhosis
2023 09 May
A new study assessed the impact of high mean arterial pressure (MAP) on renal outcomes in critically ill cirrhosis patients with septic shock (CIC). The efficacy of a high MAP strategy (80-85 mm Hg; H-MAP) was compared to a low MAP strategy (60-65 mm Hg; L-MAP) in improving 28-day mortality in CIC. Additionally, the study examined the reversal of shock,...Read more
2021 08 Jun
One of the most common causes of hospitalisation and mortality in patients with cirrhosis is sepsis and septic shock. However, despite the routine presence of this condition, there is very limited data on the choice of fluid and resuscitation protocols in sepsis-induced hypotension in cirrhosis. The F luid R esuscitation in S epsis I nduced...Read more
2020 18 Dec
1 in 5 advanced fibrosis patients evolves to cirrhosis in as little as two and a half years. The liver is the largest gland in the human body and, weighing roughly two kilograms, it is the second largest organ after the skin. Its varied functions include supplying the brain with glucose, filtering toxins out of the blood, producing proteins,...Read more
2019 10 Apr
Cirrhosis is a leading cause of morbidity and mortality throughout the world. Patients with cirrhosis may develop decompensated disease with portal hypertension and functional impairment of the liver, resulting in numerous complications including infection, variceal bleeding, hepatic encephalopathy (HE), and hepatorenal syndrome (HRS). Along...Read more
2018 10 Apr
Cirrhosis, a major worldwide health problem, has a high level of morbidity and mortality. Patients with cirrhosis who require intensive care support have high mortality rates of near 50 percent. This patient population presents numerous challenges to the intensive care provider but, unfortunately, current management strategies remain largely guided...Read more
2015 11 Apr
Standard assessments that nurses already use to care for patients can provide data that significantly improve the ability to predict survival following a liver transplant and may help improve patient outcomes. This finding is based on a study from Liver Center at Beth Israel Deaconess Medical Center (BIDMC) and published in the journal Hepatology ....Read more
2014 10 Nov
Researchers from the Mayo Clinic (Jacksonville, FA, USA) have found that the use of two new oral medications is effective in fighting hepatitis C infection amongst liver transplant patients. Given the clinical importance of the study, results have been presented in a plenary session of the American Association for the Study of Liver Diseases (The Liver...Read more
2014 09 Jun
Hepatic encephalopathy is a serious complication of advanced liver disease. As many as 45 percent of cirrhosis patients will experience a deterioration of brain function, since the damaged liver is unable to remove toxins from the blood. A study recently published in the journal Clinical Gastroenterology and Hepatology reports that probiotics can...Read more